Cardiol Therapeutics Inc.
CRDL · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Assets | – | – | – | – |
| Cash & Equivalents | $11,622 | $18,195 | $23,293 | $30,580 |
| Short-Term Investments | $0 | $0 | $0 | $0 |
| Receivables | $196 | $280 | $347 | $362 |
| Inventory | $0 | $0 | $0 | $0 |
| Other Curr. Assets | $989 | $1,299 | $1,633 | $727 |
| Total Curr. Assets | $12,807 | $19,774 | $25,272 | $31,668 |
| Property Plant & Equip (Net) | $141 | $164 | $183 | $196 |
| Goodwill | $0 | $0 | $0 | $0 |
| Intangibles | $0 | $0 | $0 | $0 |
| Long-Term Investments | $0 | $0 | $0 | $0 |
| Tax Assets | $0 | $0 | $0 | $0 |
| Other NC Assets | $0 | $0 | $0 | $0 |
| Total NC Assets | $141 | $164 | $183 | $196 |
| Other Assets | $0 | $0 | $0 | $0 |
| Total Assets | $12,948 | $19,938 | $25,455 | $31,864 |
| Liabilities | – | – | – | – |
| Payables | $0 | $7,987 | $7,716 | $6,977 |
| Short-Term Debt | $37 | $36 | $34 | $33 |
| Tax Payable | $0 | $0 | $0 | $0 |
| Deferred Revenue | $0 | $0 | $0 | $0 |
| Other Curr. Liab. | $3,253 | $0 | $0 | $0 |
| Total Curr. Liab. | $3,290 | $8,023 | $7,751 | $7,010 |
| LT Debt | $97 | $107 | $116 | $126 |
| Deferred Rev, NC | $0 | $0 | $0 | $0 |
| Deferred Tax Liab, NC | $0 | $0 | $0 | $0 |
| Other NC Liab. | $0 | $0 | $0 | $0 |
| Total NC Liab. | $97 | $107 | $116 | $126 |
| Other Liabilities | $0 | $0 | $0 | $0 |
| Cap. Leases | $134 | $143 | $151 | $159 |
| Total Liabilities | $3,387 | $8,130 | $7,867 | $7,135 |
| Equity | – | – | – | – |
| Pref Stock | $0 | $0 | $0 | $0 |
| Common Stock | $187,363 | $179,539 | $179,335 | $179,335 |
| Retained Earnings | -$205,904 | -$195,896 | -$187,542 | -$179,254 |
| AOCI | $0 | $0 | $0 | $0 |
| Other Equity | $28,103 | $28,165 | $25,794 | $24,647 |
| Total Equity | $9,561 | $11,808 | $17,588 | $24,728 |
| Supplemental Information | – | – | – | – |
| Minority Interest | $0 | $0 | $0 | $0 |
| Total Liab. & Tot. Equity | $12,948 | $19,938 | $25,455 | $31,864 |
| Net Debt | -$11,488 | -$18,052 | -$23,142 | -$30,421 |